股票质押式回购

Search documents
贝瑞基因实控人353.5万股被裁定强制变现 近4年连亏
Zhong Guo Jing Ji Wang· 2025-05-19 08:07
Core Viewpoint - The announcement highlights that a significant shareholder of Berry Genomics, Gao Yang, is subject to judicial enforcement regarding the forced liquidation of a portion of his shares due to a breach of contract with Guoxin Securities [1][2]. Group 1: Shareholder and Legal Actions - Gao Yang, the controlling shareholder of Berry Genomics, holds 31,988,723 shares, accounting for 9.05% of the total share capital [1]. - The Chengdu Financial Court has ordered the forced liquidation of 3,535,214 shares held by Gao Yang due to a breach of a stock pledge repurchase agreement with Guoxin Securities [1][2]. - The enforcement action is based on a legally effective arbitration ruling from the Shenzhen International Arbitration Court [1]. Group 2: Financial Performance - Berry Genomics reported net profits attributable to shareholders of -117 million yuan in 2021, -249 million yuan in 2022, -427 million yuan in 2023, and -192 million yuan in 2024 [3]. - The company's operating revenue for 2024 is 1,078 million yuan, a decrease of 6.36% from 2023, which had revenue of 1,151 million yuan [4]. - The net profit attributable to shareholders for 2024 improved by 54.96% compared to 2023, indicating a reduction in losses [4].
多家券商涉证券虚假陈述诉讼 中介机构风控短板亟待补齐
Shang Hai Zheng Quan Bao· 2025-04-28 20:33
Core Viewpoint - Multiple securities firms have disclosed significant litigation matters in their 2024 annual reports, highlighting risks in areas such as securities misrepresentation, stock pledge repurchase, and margin financing disputes, which reflect the risk points in the development of brokerage businesses [1] Group 1: Securities Misrepresentation - Securities misrepresentation has emerged as a major risk point leading to lawsuits against brokerage firms, where investors seek compensation from brokers for losses incurred due to the fraudulent actions of listed companies [1] - In December 2024, individual investors filed lawsuits against Meishang Ecological Landscape Co., Ltd. and Jintongling Technology Group Co., Ltd., along with five brokerage firms, demanding joint compensation for securities misrepresentation [1] - Jintongling has reported inflated or deflated profit figures from 2017 to 2022, with discrepancies reaching as high as 5774.38% in one year, leading to false disclosures in annual reports [3] Group 2: Brokerage Responses - Brokerages such as Everbright Securities and GF Securities have indicated uncertainty regarding the final amount involved in the lawsuits due to the special representative litigation procedure, making it difficult to assess the impact on current or future profits [2] Group 3: Stock Pledge Repurchase Disputes - In addition to securities misrepresentation, several brokerages are embroiled in disputes related to stock pledge repurchase transactions, with Oriental Securities reporting a default involving a principal repayment of 653 million yuan [7] - Guohai Securities has also disclosed multiple stock pledge repurchase disputes, with asset impairment provisions impacting their net profits significantly, including a reduction of 55.08 million yuan in one instance [7][8] Group 4: Legal Responsibilities of Intermediaries - The legal framework imposes joint liability on brokers when securities misrepresentation occurs, allowing investors to sue both the issuer and the broker, which has led to an increase in such cases since the 2022 judicial interpretation [5] - Legal experts emphasize that investors rely on brokers for due diligence, and if brokers fail to fulfill their duties, they may be liable for investor losses [6]